BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 4086905)

  • 21. [Prediction of nocturnal hypoglycaemia with bedtime glucose level during continuous subcutaneous insulin infusion in type 2 diabetics].
    Li M; Zhou J; Bao YQ; Lu W; Jia WP
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(42):2962-6. PubMed ID: 21211306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Study of the Carbohydrate-to-Insulin Ratio in Pregnant Women with Type 1 Diabetes on Pump Treatment.
    Bongiovanni M; Fresa R; Visalli N; Bitterman O; Suraci C; Napoli A
    Diabetes Technol Ther; 2016 Jun; 18(6):360-5. PubMed ID: 27028951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New technologies for the management of pregestational diabetes mellitus.
    Lee-Parritz A
    Obstet Gynecol Surv; 2012 Mar; 67(3):167-75. PubMed ID: 22901950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes.
    Secher AL; Madsen AB; Ringholm L; Barfred C; Stage E; Andersen HU; Damm P; Mathiesen ER
    Diabet Med; 2012 Feb; 29(2):272-7. PubMed ID: 21883435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes in pregnancy. The use of home blood glucose monitoring and intensive monitoring to ensure favourable perinatal outcome.
    Huddle KR; Myer IG; Diamond TH; Barrow VN; Hellman PR; Bolton KD; Tshabalala G; Mahlaba R
    S Afr Med J; 1987 Apr; 71(7):429-31. PubMed ID: 3551132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic women.
    Mancuso S; Caruso A; Lanzone A; Bianchi V; Massidda M; Codipietro F; Fulghesu AM
    Acta Endocrinol Suppl (Copenh); 1986; 277():112-6. PubMed ID: 3532661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.
    Kravarusic J; Aleppo G
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations.
    Rodger NW; Dupre J; Canny CL; Brown WF
    Diabetes Care; 1985; 8(5):447-55. PubMed ID: 3902423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo insulin action in type 1 (insulin-dependent) diabetic pregnant women as assessed by the insulin clamp technique.
    Schmitz O; Klebe J; Møller J; Arnfred J; Hermansen K; Orskov H; Beck-Nielsen H
    J Clin Endocrinol Metab; 1985 Nov; 61(5):877-81. PubMed ID: 3900123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the effects of conventional insulin therapy and the insulin infusion pump on blood glucose values in pregnant diabetics].
    Vozár J; Kusinová F; Komorník J; Mikulecký M; Ondrejka P
    Bratisl Lek Listy; 1986 May; 85(5):570-7. PubMed ID: 3521790
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of pregnancy in women with type 1 diabetes.
    Azar M; Lyons TJ
    Minerva Endocrinol; 2013 Dec; 38(4):339-49. PubMed ID: 24285102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of third-trimester diabetic pregnancies with the use of continuous subcutaneous insulin infusion therapy: a pilot study.
    Hertz RH; King KC; Kalhan SC
    Am J Obstet Gynecol; 1984 Jun; 149(3):256-60. PubMed ID: 6731504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modern technologies in diabetology. CSII (continuous subcutaneous insulin infusion) and CGM (continuous glucose monitoring) in clinical practice].
    Olsovský J
    Vnitr Lek; 2011 Nov; 57(11):919-22. PubMed ID: 22165697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of automatic systems for correcting blood sugar in patients with type-1 diabetes mellitus].
    Perelygina AA; Antsiferov MB; Starostina EG
    Probl Endokrinol (Mosk); 1988; 34(3):37-46. PubMed ID: 3138684
    [No Abstract]   [Full Text] [Related]  

  • 36. Continuous glucose monitoring in diabetic women following antenatal corticosteroid therapy: a pilot study.
    Refuerzo JS; Garg A; Rech B; Ramin SM; Vidaeff A; Blackwell SC
    Am J Perinatol; 2012 May; 29(5):335-8. PubMed ID: 22094918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous glucose monitoring for treatment adjustment in diabetic pregnancies--a pilot study.
    Yogev Y; Ben-Haroush A; Chen R; Kaplan B; Phillip M; Hod M
    Diabet Med; 2003 Jul; 20(7):558-62. PubMed ID: 12823237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Control of diabetes mellitus in pregnant women evaluated by the Schlichtkrul coefficient and obstetrical results].
    Kalita J; Krzyczkowska-Sendrakowska M; Michałek-Machejek D; Zdebski Z
    Ginekol Pol; 1988 Jun; 59(6):333-7. PubMed ID: 3069615
    [No Abstract]   [Full Text] [Related]  

  • 39. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII.
    Simonson DC; Tamborlane WV; Sherwin RS; Smith JD; DeFronzo RA
    Diabetes; 1985 Aug; 34 Suppl 3():80-6. PubMed ID: 3894130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes.
    Park S; Choi SB
    Am J Clin Nutr; 2002 Apr; 75(4):728-33. PubMed ID: 11916760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.